Manulife (Manufacturers Life Insurance) Portfolio holdings
AUM
$112B
1-Year Return
19.76%
This Quarter Return
+4.07%
1 Year Return
+19.76%
3 Year Return
+56.91%
5 Year Return
+121.6%
10 Year Return
+261.3%
AUM
$85.9B
AUM Growth
-$6.56B
(-7.1%)
Cap. Flow
-$10B
Cap. Flow
% of AUM
-11.67%
Top 10 Holdings %
Top 10 Hldgs %
14.9%
Holding
3,028
New
410
Increased
837
Reduced
1,624
Closed
128
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$311M |
| 2 |
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
|
+$278M |
| 3 |
iShares 1-3 Year International Treasury Bond ETF
IGOV
|
+$147M |
| 4 |
Fox Class B
FOX
|
+$135M |
| 5 |
Rogers Communications
RCI
|
+$119M |
Top Sells
| 1 |
BCE
BCE
|
+$264M |
| 2 |
DCUD
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
|
+$253M |
| 3 |
Toronto Dominion Bank
TD
|
+$242M |
| 4 |
Visa
V
|
+$232M |
| 5 |
Royal Bank of Canada
RY
|
+$191M |
Sector Composition
| 1 | Financials | 18.93% |
| 2 | Technology | 11.64% |
| 3 | Healthcare | 11.19% |
| 4 | Consumer Discretionary | 9.16% |
| 5 | Communication Services | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNR
2226
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $369K | ﹤0.01% |
54,974
+688
| +1% | +$4.62K |
|
|
IPHS
2227
DELISTED
Innophos Holdings, Inc.
IPHS
| $369K | ﹤0.01% |
12,663
+5,429
| +75% | +$158K |
|
2228
Bally's
BALY
$491M
| $367K | ﹤0.01% |
+12,338
| New | +$367K |
|
|
RVNC
2229
DELISTED
Revance Therapeutics, Inc.
RVNC
| $367K | ﹤0.01% |
28,268
+2,691
| +11% | +$34.9K |
|
2230
Kura Oncology
KURA
$766M
| $366K | ﹤0.01% |
18,604
+7,874
| +73% | +$155K |
|
2231
Northern Oil and Gas
NOG
$2.51B
| $365K | ﹤0.01% |
18,945
+5,762
| +44% | +$111K |
|
2232
OraSure Technologies
OSUR
$243M
| $365K | ﹤0.01% |
39,318
-883
| -2% | -$8.2K |
|
2233
Surmodics
SRDX
$461M
| $365K | ﹤0.01% |
8,466
+3,592
| +74% | +$155K |
|
2234
Evolent Health
EVH
$1.08B
| $364K | ﹤0.01% |
45,765
+932
| +2% | +$7.41K |
|
2235
Hyster-Yale Materials Handling
HY
$655M
| $364K | ﹤0.01% |
6,584
+2,647
| +67% | +$146K |
|
2236
Argan
AGX
$3.21B
| $363K | ﹤0.01% |
8,959
-675
| -7% | -$27.4K |
|
2237
Akebia Therapeutics
AKBA
$793M
| $363K | ﹤0.01% |
74,931
+17,262
| +30% | +$83.6K |
|
|
RUBY
2238
DELISTED
Rubius Therapeutics, Inc
RUBY
| $363K | ﹤0.01% |
23,078
+9,573
| +71% | +$151K |
|
2239
BrightView Holdings
BV
$1.34B
| $362K | ﹤0.01% |
19,362
+8,409
| +77% | +$157K |
|
2240
Mr. Cooper
COOP
$14.1B
| $362K | ﹤0.01% |
45,250
-1,246
| -3% | -$9.97K |
|
2241
Precigen
PGEN
$1.23B
| $362K | ﹤0.01% |
47,205
-4,176
| -8% | -$32K |
|
2242
DexCom
DXCM
$29.8B
| $361K | ﹤0.01% |
9,624
-480
| -5% | -$18K |
|
2243
Wave Life Sciences
WVE
$1.14B
| $361K | ﹤0.01% |
13,843
+1,057
| +8% | +$27.6K |
|
|
WLH
2244
DELISTED
WILLIAM LYON HOMES
WLH
| $360K | ﹤0.01% |
19,757
+7,851
| +66% | +$143K |
|
2245
Heidrick & Struggles
HSII
$1.05B
| $359K | ﹤0.01% |
11,981
-336
| -3% | -$10.1K |
|
2246
TrueCar
TRUE
$199M
| $359K | ﹤0.01% |
65,674
+2,867
| +5% | +$15.7K |
|
2247
NIO
NIO
$13.6B
| $358K | ﹤0.01% |
+140,300
| New | +$358K |
|
|
ITCI
2248
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $358K | ﹤0.01% |
27,618
-1,274
| -4% | -$16.5K |
|
2249
Clearway Energy Class A
CWEN.A
$3.21B
| $356K | ﹤0.01% |
21,972
-1,959
| -8% | -$31.7K |
|
2250
Wayfair
W
$11.7B
| $356K | ﹤0.01% |
2,435
+16
| +0.7% | +$2.34K |
|